This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

David Younger, Ph.D.
Co-Founder & CEO at A-Alpha Bio


David Younger is the CEO and Co-Founder of A-Alpha Bio, a seed stage biotechnology company using synthetic biology and next generation sequencing technology to develop better drugs with more comprehensive data. David invented A-Alpha Bio’s AlphaSeq platform with Scientific Advisors David Baker and Eric Klavins at the University of Washington, where he earned his PhD in Bioengineering. David’s technical expertise spans synthetic biology, protein engineering, and Next Generation Sequencing assay development.

Agenda Sessions

  • Antibody Selection and Screening in Early Discovery

  • Massively Multiplexed and Quantitative Characterization of Antibody-antigen Interactions

    On Demand